Alopecia Areata Incognita: A Hypothesis

    January 1987 in “ Dermatology ”
    Alfredo Rebora
    Image of study
    TLDR Alopecia areata may appear differently depending on the individual's type of hair loss and scalp condition.
    In 1987, Alfredo Rebora hypothesized that alopecia areata (AA) is more likely to manifest as distinct patches in individuals with a low percentage of telogen hairs and who have a group of hairs in the early anagen VI subphase within a specific scalp zone. Conversely, those with androgenetic alopecia (AGA) may experience a diffuse form of AA, termed alopecia areata incognita, which resembles telogen effluvium. This hypothesis was supported by a study involving 90 male patients with AA and 107 control patients with other dermatological conditions, which showed that AA was more common in individuals with normal scalps or minor forms of seborrheic alopecia, indicating that the presentation of AA may vary depending on the extent of balding present.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community My scalp punch biopsy results🤔?

      in Female  9 upvotes 1 year ago
      Female using Rogaine foam for hair loss had scalp punch biopsy, diagnosed with Androgenetic Alopecia (AGA). Doctor recommended starting Spironolactone 50mg.

      community AGA evaluation and first steps - BEGINNER MEGAPOST

      in Chat  76 upvotes 3 months ago
      The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.

      community results in just 2 months🙏🙏19(M)

      in Progress Pictures  72 upvotes 10 months ago
      A 19-year-old user shared impressive hair growth results after using 5% topical minoxidil foam and 1mg finasteride for two months, along with vitamin D. They recommend this regimen for others, noting significant improvements in hair thickness and health.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

    Related Research

    7 / 7 results